Protein detail
KSYK
Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)
Entry name KSYK | UniProt ID | EVMP confidence score 0.28 |
Supporting publications (n) 4 | Transmembrane count | Protein classification Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted intracellular proteins |
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30Basic Information
Protein Names
Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)
Protein Class (6)
Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted intracellular proteins
Protein Function (8)
- Predicted intracellular proteins
- ENZYME proteins:Transferases
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Enzymes
- Cancer-related genes
- Kinases:Tyr protein kinases
- Disease related genes
- FDA approved drug targets:Small molecule drugs
Ensembl
Entrez Gene Symbol
Gene Description
Spleen associated tyrosine kinase
Chromosome
9
Position
90801787-90898549
Supporting publications (n)
4
EVMP confidence score
0.28
Fluorescence & Localization
Cell SpecificPlateletsSingle-Nuclei Brain Specificendothelial cell
Function & Pathway
Protein Function (8)
- Predicted intracellular proteins
- ENZYME proteins:Transferases
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Enzymes
- Cancer-related genes
- Kinases:Tyr protein kinases
- Disease related genes
- FDA approved drug targets:Small molecule drugs
Cellular Component (8)
Molecular Function (17)
- GO:0001784 phosphotyrosine residue binding
- GO:0004672 protein kinase activity
- GO:0004674 protein serine/threonine kinase activity
- GO:0004713 protein tyrosine kinase activity
- GO:0004715 non-membrane spanning protein tyrosine kinase activity
- GO:0005102 signaling receptor binding
- GO:0005178 integrin binding
- GO:0005515 protein binding
- GO:0005524 ATP binding
- GO:0016170 interleukin-15 receptor binding
Page 1 of 2
Biological Process (3)
KEGG (17)
- hsa04064 NF-kappa B signaling pathway
- KEGG:hsa04072 Phospholipase D signaling pathway
- KEGG:hsa04151 PI3K-Akt signaling pathway
- KEGG:hsa04380 Osteoclast differentiation
- KEGG:hsa04611 Platelet activation
- KEGG:hsa04613 Neutrophil extracellular trap formation
- KEGG:hsa04625 C-type lectin receptor signaling pathway
- KEGG:hsa04650 Natural killer cell mediated cytotoxicity
- KEGG:hsa04662 B cell receptor signaling pathway
- KEGG:hsa04664 Fc epsilon RI signaling pathway
Page 1 of 2
Reactome (39)
- R-hsa-1280218 adaptive immune system
- R-hsa-983695 antigen activates b cell receptor bcr leading to generation of second messengers
- R-hsa-9662851 anti inflammatory response favouring leishmania parasite infection
- R-hsa-5607764 clec7a dectin 1 signaling
- R-hsa-1280215 cytokine signaling in immune system
- R-hsa-5621481 c type lectin receptors clrs
- R-hsa-2172127 dap12 interactions
- R-hsa-2424491 dap12 signaling
- R-hsa-5621480 dectin 2 family
- R-hsa-2871809 fceri mediated ca 2 mobilization
Page 1 of 4
Mediation Categories (6)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence101
Enzyme-Mediated Modification (29)
29 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| SYK | CLEC6A | Q6EIG7 | Y | 352 | phosphorylation | REACH_ProtMapperProtMapper | ProtMapper:29386115 |
| SYK | BCR | P11274 | Y | 352 | phosphorylation | REACH_ProtMapperSparser_ProtMapperProtMapper | ProtMapper:26478008 |
| SYK | MAF1 | Q9H063 | Y | 352 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:22896635 |
| SYK | EGFR | P00533 | Y | 525 | phosphorylation | KEA | KEA:17570479 |
| SYK | FYN | P06241 | Y | 348 | phosphorylation | KEA | KEA:17570479 |
| SYK | FYN | P06241 | Y | 352 | phosphorylation | KEA | KEA:17570479 |
| SYK | INSR | P06213 | Y | 348 | phosphorylation | KEA | KEA:17570479 |
| SYK | INSR | P06213 | Y | 526 | phosphorylation | KEA | KEA:17570479 |
| SYK | LCK | P06239 | Y | 526 | phosphorylation | KEA | KEA:17570479 |
Page 3 of 3Previous
Ligand-Receptor Signaling (13)
13 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| plasma_membrane | plasma_membrane | Cellinker | |||||
| plasma_membrane | plasma_membrane | OmniPath | |||||
| receptor | receptor | scConnect | Yes |
Page 2 of 2Previous
Regulatory Interaction Network (56)
56 records.
Protein Complex Composition (2)
Isolation & Detection Technology (1)
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential UltracentrifugationSize Exclusion ChromatographyImmunoaffinity Capture | Mass Spectrometry | 1 | 38113368 |
Sequence, Structure & Domains
Sequences
Length
635
Mass
72,066
Sequence
MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=Long; IsoId=P43405-1; Sequence=Displayed; Name=Short; IsoId=P43405-2; Sequence=VSP_005010
Alternative Sequence
283..305; Missing (in isoform Short)
3D Structural Models
Turn
567..569; 572..575
Helix
10..12; 22..31; 85..92; 119..136; 140..158; 163..165; 175..183; 237..244; 342..344; 346..348; 351..353; 360..363; 367..369; 411..424; 456..462; 468..487; 497..499; 513..515; 536..538; 541..546; 551..566; 578..586; 599..608; 613..615; 619..624
Beta Strand
38..43; 47..49; 51..57; 60..68; 74..76; 82..84; 99..101; 169..172; 184..186; 187..189; 192..201; 203..209; 212..220; 221..224; 226..228; 229..231; 234..236; 251..253; 370..372; 377..380; 384..391; 393..409; 435..449; 500..504; 507..510; 524..527; 548..550; 589..591
3D Structure
NMR spectroscopy (2); X-ray crystallography (91)
Domain & Motif Annotations
Domain (CC)
The SH2 domains mediate the interaction of SYK with the phosphorylated ITAM domains of transmembrane proteins. Some proteins like CLEC1B have a partial ITAM domain (also called hemITAM) containing a single YxxL motif. The interaction with SYK requires CLEC1B homodimerization.
Domain (FT)
15..107; SH2 1; 168..259; SH2 2; 371..631; Protein kinase
Region
108..167; Interdomain A; 260..370; Interdomain B
Protein Families (3)
- Protein kinase superfamily
- Tyr protein kinase family
- SYK/ZAP-70 subfamily
Sequence Similarities
Belongs to the protein kinase superfamily. Tyr protein kinase family. SYK/ZAP-70 subfamily.
Clinical Relevance
Disease Involvement (3)
Cancer-related genesDisease variantFDA approved drug targets
Related Diseases (17)
Acquired hypomelanotic disorderAcute myeloid leukaemiaAllergic/hypersensitivity disorderAsthmaAtopic eczemaB-cell lymphomaChronic obstructive pulmonary diseaseCutaneous lupus erythematosusDiabetes mellitusDiffuse large B-cell lymphomaMalignant haematopoietic neoplasmMature B-cell leukaemiaRheumatoid arthritisSolid tumour/cancerThrombocytopeniaThrombosisUrticaria
Biomarker
Phase 1; Phase 2; Investigative; Phase 3; Approved
Drug Targets
FDA approved drug targets
Drugs (35)
CYC-116FOSTAMATINIBNULLCEDIRANIBPRT-2607P505-15PACLITAXELR-343GW441756XCHEMBL:CHEMBL379975R-348NVP-TAE684GUSACITINIBR-112LANRAPLENIBMIVAVOTINIB CITRATER-333FOSTAMATINIB DISODIUMSP-600125ENTOSPLETINIBCERDULATINIBTAMATINIBPD-0166285CHEMBL:CHEMBL535331CEVIDOPLENIB DIMESYLATEILORASERTIBADAVOSERTIBRG-1530DASATINIB ANHYDROUSIMATINIBERLOTINIBENTRECTINIBSOVLEPLENIBCENISERTIBGSK2646264
Interaction Protein (8)
ENSG00000110395ENSG00000112773ENSG00000145675ENSG00000146648ENSG00000154127ENSG00000155313ENSG00000158869ENSG00000182866
Interaction Count
8
Interaction Dataset
intact_biogrid
Supporting Publications4
| PMID | Title | Related sentences |
|---|---|---|
| 38731868 | The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer. | No related sentences available |
| 40091455 | Potential Role of Menstrual Fluid-Derived Small Extracellular Vesicle Proteins in Endometriosis Pathogenesiss. | No related sentences available |
| 40098346 | Toward Identification of Markers for Brain-Derived Extracellular Vesicles in Cerebrospinal Fluid: A Large-Scale, Unbiased Analysis Using Proximity Extension Assays. | No related sentences available |
| 41227296 | Extracellular Vesicles Profiling in Acute Myeloid Leukemia Cell Lines: A Proteomic Characterization. | No related sentences available |